Lipids & Metabolic

Cannabis use is associated with double the risk of diabetic ketoacidosis among patients with type 1…
A 13-year study of type 2 diabetes patients has found metformin, one of the world’s highest-…
Coronary artery calcium (CAC) scoring could be the key to determining which patients are most…
Biopharmaceutical company Amarin announced top-line results for its purified eicosapentaenoic acid…
With the American Heart Association’s 2018 Scientific Sessions set for Nov. 10-12 in Chicago, two…
Another drug with the potential to lower cholesterol beyond maximally tolerated statin therapy is…
A new study published in the European Journal of Preventive Cardiology identified a strong link…
Low blood pressure (BP) and weight loss could signal an impending diagnosis of dementia, while…
Figures released by England’s National Health Service have revealed that around 500 U.K. residents…
The FDA has approved canagliflozin (Invokana) to reduce the risk of major adverse cardiovascular…
Evolocumab appears to be equally effective at reducing LDL cholesterol and preventing…
Amgen is slashing the list price of its PCSK9 inhibitor evolocumab (Repatha) by almost 60 percent,…